November/December 2021

5Q with Dennis Han, MD

Dennis Han, MD

Déjà Vu

Several advances working their way through clinical trials have the potential to change our approach to patient care.

Allen C. Ho, MD, and Robert L. Avery, MD

Watch For Retinal Findings With Systemic Pazopanib

Delayed wound healing after retinal surgery may be a side effect associated with this chemotherapy.

Rita Vieira, MD, Corresponding Author; João Coelho, MD; and João Nuno Melo Beirão, MD, PhD

Anterior Signs of a Posterior Problem

Nevus of Ota, which affects the ophthalmic and maxillary trigeminal nerve, causes hyperpigmentation of the eye.

Keaton Taber, BS; Michael Weaver, DO; Chris Jacquinot, OD; and Heeral R. Shah, MD | SECTION EDITOR

Establishing the Pediatric Retina Society

Top lectures at the 2021 Advances in Pediatric Retina Course included the long-anticipated creation of a pediatric retina organization.

Shwetha Mangalesh, MBBS, and Nita Valikodath, MD, MS

Experts Weigh in on Pharmacologic Therapy for Retinal Disease

Aspen Retinal Detachment Society panelists discussed various management strategies for DME and RVO.

By the Staff of Retina Today

The Diabetic Eye Disease Pipeline in 2021

The future remains bright with many clinical trials reporting promising data.

Xuejing Chen, MD, MS; Arshad M. Khanani, MD, MA; and Caroline R. Baumal, MD

Advances in Wet AMD Research

Several drug candidates are showing promise, with plenty more in the works.

Abtin Shahlaee, MD; Allen Chiang, MD; and Allen C. Ho, MD

Geographic Atrophy: Targeting the Complement Pathway

This form of AMD is creating a lot of buzz with novel therapeutics under investigation.

Yingna Liu, MD, and Jeffrey S. Heier, MD

Surgical Innovations to Treat Medical Retinal Diseases

Several advances working their way through clinical trials have the potential to change our approach to patient care.

Jordan D. Deaner, MD, and Lejla Vajzovic, MD

Expanding Your Toolbox With Biosimilars

New options are under investigation—and some are already headed to the retina clinic.

Hong-Uyen Hua, MD, and Aleksandra Rachitskaya, MD

Long-Term Outcomes of Anti-VEGF Therapy

Data out to 5 years provide new insights into efficacy and burden of treatment in AMD and other conditions.

Thomas A. Ciulla, MD, MBA, and Rehan M. Hussain, MD

The Case of an Iris Melanoma Masquerader

A careful examination is necessary to properly diagnose iridocorneal endothelial syndrome with iris nevus.

Mallory E. Bowers, PhD; Ahmed Sheikh, MD; and Carol L. Shields, MD

An Aggressive Presentation of Proliferative Retinopathy

This young patient presented with ocular sequelae of uncontrolled type 1 diabetes and systemic erythematosus lupus.

Eduardo Zans, MD